Chwilio Deddfwriaeth

Council Directive of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products (76/768/EEC) (repealed)

 Help about what version

Pa Fersiwn

 Help about advanced features

Nodweddion Uwch

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE

Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

ANNEX IIU.K. [F1LIST OF SUBSTANCES WHICH MUST NOT FORM PART OF THE COMPOSITION OF COSMETIC PRODUCTS]

Textual Amendments

1.

N-5-Chlorobenzoxazol-2-ylacetamide

2.

[F12 -Acetoxyethyltrimethylammonium hydroxide (acetylcholine) and its salts]

3.

Deanol aceglumate(1)

4.

Spironolactone*

5.

[F1[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid and its salts]

6.

Methotrexate*

7.

Aminocaproic acid* and its salts

8.

Cinchophen*, its salts, derivatives and salts of these derivatives

9.

Thyropropic acid* and its salts

10.

Trichloroacetic acid

11.

Aconitum napellus L. (leaves, roots and galenical preparations)

12.

Aconitine (principal alkaloid of Aconitum napellus L.) and its salts

13.

Adonis vernalis L. and its preparations

14.

Epinephrine*

15.

Rauwolfia serpentina alkaloids and their salts

16.

Alkyne alcohols, their esters, ethers and salts

17.

Isoprenaline*

18.

Allyl isothiocyanate

19.

Alloclamide* and its salts

20.

Nalorphine*, its salts and ethers

21.

Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe

22.

Aniline, its salts and its halogenated and sulphonated derivatives

23.

Betoxycaine* and its salts

24.

Zoxazolamine*

25.

Procainamide*, its salts and derivatives

26.

Benzidine

27.

Tuaminoheptane*, its isomers and salts

28.

Octodrine* and its salts

29.

[F12-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts]

30.

1,3-dimethylpentylamine and its salts

31.

4-Aminosalicylic acid and its salts

32.

Toluidines, their isomers, salts and halogenated and sulphonated derivatives

33.

Xylidines, their isomers, salts and halogenated and sulphonated derivatives

34.

[F1Imperatorin (9-(3-methoxylbut-2-enyloxy)furo[3,2-g]chromen-7-one)]

35.

Ammi majus and its galenical preparations

36.

2,3-Dichloro-2-methylbutane

37.

Substances with androgenic effect

38.

Anthracene oil

39.

Antibiotics [F2]

40.

Antimony and its compounds

41.

Apocynum cannabinum L. and its preparations

42.

[F1Apomorphine (R 5,6,6a, 7-tetrahydro-6-methyl-4 H -dibenzo [de,g]quinoline-10,11-diol) and its salts]

43.

Arsenic and its compounds

44.

Atropa belladonna L. and its preparations

45.

Atropine, its salts and derivatives

46.

[F3Barium salts, with the exception of barium sulphate, barium sulphide under the conditions laid down in Annex III, Part 1, and lakes, salts and pigments prepared from the colouring agents listed with the reference ( 5 ) in Annex III, Part 2 and Annex IV, Part 2.]

47.

Benzene

48.

[F1Benzimidazol-2(3 H )-one]

49.

[F1Benzazepines and benzodiazepines]

50.

[F11-Dimethylaminomethyl-1-methylpropyl benzoate (amylocaine) and its salts]

51.

[F12,2,6-Trimethyl-4-piperidyl benzoate (benzamine) and its salts]

52.

[F1Isocarboxazid*]

53.

Bendroflumethiazide* and its derivatives

54.

Beryllium and its compounds

55.

Bromine, elemental

56.

Bretylium tosilate*

57.

Carbromal*

58.

Bromisoval*

59.

Brompheniramine* and its salts

60.

Benzilonium bromide*

61.

Tetrylammonium bromide*

62.

Brucine

63.

Tetracaine* and its salts

64.

Mofebutazone*

65.

Tolbutamide*

66.

Carbutamide*

67.

Phenylbutazone*

68.

Cadmium and its compounds

69.

Cantharides, Cantharis vesicatoria

70.

(1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride (cantharidin)

71.

Phenprobamate*

72.

[F1Nitroderivatives of carbazole]

73.

Carbon disulphide

74.

Catalase

75.

Cephaeline and its salts

76.

Chenopodium ambrosioides (essential oil)

77.

2,2,2-Trichloroethane-1,1-diol

78.

Chlorine

79.

Chlorpropamide*

80.

[F1Diphenoxylate* hydrochloride]

81.

4-Phenylazophenylene-1,3-diamine citrate hydrochloride (chrysoidine citrate hydrochloride)

82.

Chlorzoxazone*

83.

2-Chloro-6-methylpyrimidin-4-yldimethylamine (crimidine-ISO)

84.

Chlorprothixene* and its salts

85.

Clofenamide*

86.

[F1N,N -bis(2-chloroethyl)methylamine N -oxide and its salts]

87.

Chlormethine* and its salts

88.

Cyclophosphamide* and its salts

89.

Mannomustine* and its salts

90.

Butanilicaine* and its salts

91.

[F1Chlormezanone*]

92.

Triparanol*

93.

2-[2(4-Chiorophenyl)-2-phenylacetyl] indane-1,3-dione (chlorophacinone-ISO)

94.

Chlorphenoxamine*

95.

[F12-[2-(4-Chlorophenyl)-2-phenylacetyl]indan 1,3-dione (chlorophacinone - ISO)]

96.

Chloroethane

97.

Chromium; chromic acid and its salts

98.

Claviceps purpurea Tul., its alkaloids and galenical preparations

99.

Conium maculatum L. (fruit, powder, galenical preparations)

100.

Glycyclamide*

101.

Cobalt benzenesulphonate

102.

Colchicine, its salts and derivatives

103.

Colchicoside and its derivatives

104.

Golchicum autumnale L. and its galenical preparations

105.

Convallatoxin

106.

Anamirta cocculus L. (fruit)

107.

Croton tiglium (oil)

108.

1-Butyl-3-(N-crotonoylsulphanilyl)urea

109.

Curare and curarine

110.

Synthetic curarizants

111.

Hydrogen cyanide and its salts

112.

[F12-α-Cyclohexylbenzyl( N,N,N',N', -tetraethyl)trimethylenediamine (phenetamine)]

113.

Cyclomenol* and its salts

114.

Sodium hexacyclonate*

115.

Hexapropymate*

116.

Dextropropoxyphene*

117.

[F1O,O' -Diacetyl- N -allyl- N -normorphine]

118.

Pipazetate* and its salts

119.

[F15 -(α β -Dibromophenethyl)-5-methylhydantoin]

120.

[F1N,N' -Pentamethylenebis (trimethylammonium salts), e.g. pentamethonium bromide*]

121.

[F1N,N' -[(Methylimino)diethylene]bis(ethyldimethylammonium) salts, e.g. azamethonium bromide*]

122.

Cyclarbamate*

123.

Clofenotane*; DDT (ISO)

124.

[F1N,N' -Hexamethylenebis(trimethylammonium) salts, e.g. hexamethonium bromide*]

125.

Dichloroethanes (ethylene chlorides)

126.

Dichloroethylenes (acetylene chlorides)

127.

Lysergide* and its salts

128.

[F12-Diethylaminoethyl-3-hydroxy-4-phenylbenzoate and its salts]

129.

Cinchocaine* and its salts

130.

3-Diethylaminopropyl cinnamate

131.

[F1O,O' -Diethyl O -4-nitrophenyl phosphorothioate (parathion-lSO)]

132.

[F1[Oxalylbisiminoethylene)]bis[( o -chlorobenzyl)diethylammonium salts], e.g. ambenomium cloride*]

133.

Methyprylon* and its salts

134.

Digitaline and all heterosides of Digitalis purpurea L.

135.

7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline (xanthinol)

136.

Dioxethedrin* and its salts

137.

Piprocurarium*

138.

Propyphenazone*

139.

Tetrabenazine* and its salts

140.

Captodiame*

141.

Mefeclorazine* and its salts

142.

Dimethylamine

143.

[F11,1-Bis(dimethylaminomethyl)propyl benzoate (amydricaine, alypine) and its salts]

144.

Methapyrilene* and its salts

145.

Metamfepramone* and its salts

146.

Amitriptyline* and its salts

147.

Metformin* and its salts

148.

Isosorbide dinitrate*

149.

Malononitrile

150.

Succinonitrile

151.

Dinitrophenol isomers

152.

Inproquone*

153.

Dimevamide* and its salts

154.

Diphenylpyraline* and its salts

155.

Sulfinpyrazone*

156.

[F1N -(3-Carbamoyl-3,3-diphenylpropyl)- N,N -diisopropylmethyl-ammonium salts, e.g. isopropamide iodide*]

157.

Benactyzine*

158.

Benzatropine* and its salts

159.

Cyclizine* and its salts

160.

[F15,5-Diphenyl-4-imidazolidone]

161.

Probenecid*

162.

Disulfiram*; thiram (ISO)

163.

Emetine, its salts and derivatives

164.

Ephedrine and its salts

165.

Oxanamide* and its derivatives

166.

Eserine or physostigmine and its salts

167.

Esters of 4-aminobenzoic acid, with the free amino group, with the exception of that given in [F4Annex VII, Part 2]

168.

Choline salts and their esters, e.g. choline chloride

169.

Caramiphen* and its salts

170.

Diethyl 4-nitrophenyl phosphate

171.

Metethoheptazine* and its salts

172.

Oxpheneridine* and its salts

173.

Ethoheptazine* and its salts

174.

Metheptazine* and its salts

175.

Methylphenidate* and its salts

176.

Doxylamine* and its salts

177.

Tolboxane*

178.

[F5 [X14-Benzyloxyphenol and 4-ethoxyphenol] ]

179.

Parethoxycaine* and its salts

180.

Fenozolone*

181.

Glutethimide* and its salts

182.

Ethylene oxide

183.

Bemegride* and its salts

184.

Valnoctamide*

185.

Haloperidol*

186.

Paramethasone*

187.

Fluanisone*

188.

Trifluperidol*

189.

Fluoresone*

190.

Fluorouracil*

191.

[F1Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with the exception of those given in Annex III, Part 1]

192.

Furfuryltrimethylammonium salts, e.g. furtrethonium iodide*

193.

Galantamine*

194.

Progestogens [F2]

195.

1,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO)

196.

[F1(1 R ,4 S ,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4: 5 ,8-dimethano-naphthalene (endrin-ISO)]

197.

Hexachloroethane

198.

(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethano-naphthalene (isodrin-ISO)

199.

Hydrastine, hydrastinine and their salts

200.

Hydrazides and their salts

201.

Hydrazine, its derivatives and their salts

202.

Octamoxin* and its salts

203.

Warfarin* and its salts

204.

[F1Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl) acetate and salts of the acid]

205.

Methocarbamol*

206.

Propatylnitrate*

207.

[F14,4'-Dihydroxy-3,3'-(3-methylthiopropylidene) dicoumarin]

208.

Fenadiazole*

209.

Nitroxoline* and its salts

210.

Hyoscyamine, its salts and derivatives

211.

Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations)

212.

Pemoline* and its salts

213.

Iodine

214.

[F1Decamethylenebis(trimethylammonium) salts, e.g. decamethonium bromide]

215.

Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations)

216.

(2-Isopropylpent.4-enoyl)urea (apronalide)

217.

[F1α-Santonin [(3S,5a R ,9b S )-3,3a,4,5,5a,9b-hexahydro-3,5a,9-trimethylnaphto [1,2-b] furan-2,8-dione]]

218.

Lobelia inflata L. and its galenical preparations

219.

Lobeline* and its salts

220.

Barbiturates

221.

[F6Mercury and its compounds, except those special cases included [F7in Annex VI, Part 1] ]

222.

3,4,5-Trimethoxyphenethylamine and its salts

223.

Metaldehyde

224.

2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts

225.

Coumetarol*

226.

Dextromethorphan* and its salts

227.

2-Methylheptylamine and its salts

228.

Isometheptene* and its salts

229.

Mecamylamine*

230.

Guaifenesin*

231.

Dicoumarol*

232.

Phenmetrazine*, its derivatives and salts

233.

Thiamazole*

234.

[F13,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5 H -pyrano [3,2-c]-[1] benzopyran-5-one (cyclocoumarol)]

235.

Carisoprodol*

236.

Meprobamate*

237.

Tefazoline* and its salts

238.

Arecoline

239.

Poldine metilsulfate*

240.

Hydroxyzine*

241.

2-Naphthol

242.

1-and 2-Naphthylamines and their salts

243.

[F13-(1-Naphthyl)-4-hydroxycoumarin]

244.

Naphazoline* and its salts

245.

Neostigmine and its salts (e.g. neostigmine bromide*)

246.

Nicotine and its salts

247.

Amyl nitrites

248.

Inorganic nitrites, with the exception of sodium nitrite

249.

Nitrobenzene

250.

Nitrocresols and their alkali metal salts

251.

Nitrofurantoin*

252.

Furazolidone*

253.

Propane-1,2,3-triyl trinitrate

254.

Acenocoumarol*

255.

Alkali pentacyanonitrosylferrate (2-)

256.

Nitrostilbenes, their homologues and their derivatives

257.

Noradrenaline and its salts

258.

Noscapine* and its salts

159.

Guanethidine* and its salts

260.

Oestrogens [F8]

261.

Oleandrin

262.

Chlortalidone*

263.

Pelletierine and its salts

264.

Pentachloroethane

265.

Pentaerithrityl tetranitrate*

266.

Petrichloral*

267.

Octamylamine* and its salts

268.

[F1Picric acid]

269.

Phenacemide*

270.

Difendoxazine*

271.

[F12-Phenylindan-1,3-dione (phenindione)]

272.

Ethylphenacemide*

273.

Phenprocoumon*

274.

Fenyramidol*

275.

Triamterene* and its salts

276.

[F1Tetraethyl pyrophosphate; TEPP (ISO)]

277.

Tritolyl phosphate

278.

Psilocybine*

279.

Phosphorus and metal phosphides

280.

Thalidomide* and its salts

281.

Physostigma venenosum Balf.

282.

Picrotoxin

283.

Pilocarpine and its salts

284.

[F1α-Piperidin-2-ylbenzyl acette (SIC! acetate) laevorotatory threoform (levophacetoperane) and its salts]

285.

Pipradrol* and its salts

286.

Azacyclonol* and its salts

287.

Bietamiverine*

288.

Butopiprine* and its salts

289.

Lead and its [F9compounds, with the exception of that mentioned in Annex III, No 55 under the conditions stated]

290.

Coniine

291.

Prunus laurocerasus L. (‘cherry laurel water’)

292.

Metyrapone*

293.

[F10Radioactive substances, as defined by Directive 96/29/Euratom (2) laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation.]

294.

Juniperus sabina L. (leaves, essential oil and galenical preparations)

295.

Hyoscine, its salts and derivatives

296.

Gold salts

297.

[F4Selenium and its compounds with the exception of selenium disulphiele under the conditions set out under reference No 49 in Annex Ill, Part 1]

298.

Solanum nigrum L. and its galenical preparations

299.

Sparteine and its salts

300.

Glucocorticoids

301.

Datura stramonium L. and its galenical preparations

302.

Strophantines, their aglucones and their respective derivatives

303.

Strophantus species and their galenical preparations

304.

Strychnine and its salts

305.

Strychnos species and their galenical preparations

306.

Narcotics, natural and synthetic: All substances listed in Tables I and II of the single Convention on narcotic drugs signed in New York on 30 March 1961

307.

[F1Sulphonamides (sulphanilamide and its derivatives…) and their salts obtained by substitution of one or more H-atoms of the -NH 2 groups) and their salts]

308.

Sultiame*

309.

Neodymium and its salts

310.

Thiotepa*

311.

Pilocarpus jaborandi Holmes and its galenical preparations

312.

Tellurium and its compounds

313.

[F1Xylometazoline* and its salts]

314.

Tetrachloroethylene

315.

Carbon tetrachloride

316.

Hexaethyl tetraphosphate

317.

Thallium and its compounds

318.

Thevetia neriifolia Juss., glycoside extract

319.

Ethionamide*

320.

Phenothiazine* and its compounds

321.

[F1Thiourea and its derivatives, with the exception of the one listed in Annex III, Part 1]

322.

Mephenesin* and its esters

323.

Vaccines, toxins or serums listed in the Annex to the second Council Directive of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products (OJ No L 147, 9. 6. 1975, p. 13)

324.

Tranylcypromine* and its salts

325.

Trichloronitromethane (chloropicrine)

326.

2,2,2-Tribromoethanol (tribromoethyl alcohol)

327.

Trichiormethine* and its salts

328.

Tretamine*

329.

Gallamine triethiodide*

330.

Urginea scilla Stern. and its galenical preparations

331.

Veratrine, its salts and galenical preparations

332.

Schoenocaulon olficinale Lind. (seeds and galenical preparations)

333.

[F11Veratrum Spp . and their preparations]

334.

Vinyl chloride monomer

335.

Ergocalciferol* and cholecalciferol (vitamins D2 and D3)

336.

Salts of O-alkyldithiocarbonic acids

337.

Yobimbine and its salts

338.

Dimethyl sulfoxide*

339.

Diphenhydramine* and its salts

340.

4-tert-Butylphenol

341.

4-tert-Butylpyrocatechol

342.

Dihydrotachysterol

343.

Dioxane

344.

Morpholine and its salts

345.

Pyretbrum album L. and its galenical preparations

346.

[F12-[4-Methoxybenzyl- N -(2-pyridyl)amino]ethyldimethylamine maleate]

347.

Tripelennamine*

348.

Tetrachlorosalicylanilides

349.

Dichlorosalicylanilides

350.

[F1Tetrabromosalicylanilides [F12]

351.

Dibromosalicylanilides ] [F12]

352.

Bithionol*

353.

Thiuram monosulphides

354.

Thiuram disulphides

355.

Dimethylformamide

356.

4-Phenylbut-3-en-2-one

357.

Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol except for normal content in natural essences used

358.

[F13Furocoumarines (e.g. trioxysalan*, 8-methoxypsoralen, 5-methoxypsoralen) except for normal content in natural essences used.

In sun protection and in bronzing products, furocoumarines shall be below 1 mg/kg.]

359.

Oil from the seeds of Laurus nobilis L.

360.

[F1Safrole except for normal content in the natural essences used and provided the concentration does not exceed:

  • 100 ppm in the finished product,

  • 50 ppm in products for dental and oral hygiene, and provided that Safrole is not present in toothpastes intended specifically for children]

361.

5,5'-Di-isopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite

362.

[F14. . . . .]

362.

[F153'-Ethyl-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-2'-acetonaphthone or 7-acetyl-6-ethyl-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphtalen]

363.

[F16O -phenylenediamine and its salts

364.

4-methyl- m -phenylenediamine and its salts.]

365.

[F14. . . . .]

365.

[F15Aristolochic acid and its salts; Aristolochia spp. and their preparations]

366.

[F17Chloroform

367.

[F14. . . . .]

367.

[F152,3,7,8-Tetra chlorodibenzo-p-dioxin]

368.

2,6-Dimethyl-1,3-dioxan-4-yl acetate (Dimethoxane)

369.

Pyrithione sodium (INNM)]

370.

[F18N -(Trichloromethylthio)-4-cyclohexene-1,2-dicarboximide (captan)

371.

2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane (hexachlorophene)]

372.

[F14. . . . .]

373.

[F14. . . . .

374.

. . . . .]

372.

[F19 [F156-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide (minoxidil) and its salts

373.

3,4',5-Tribromosalicylanilide

374.

Phytolacca spp. and their preparations]

375.

Tretinoin (retinoic acid and its salts)

376.

1-Methoxy-2,4-diaminobenzene (2,4-diaminoanisole - CI 76050) [F9and their salts]

377.

1-Methoxy-2,5-diaminobenzene (2,5-diaminoanisole) [F9and their salts]

378.

Colouring agent CI 12140

379.

Colouring agent CI 26105

380.

Colouring agent CI 42555

Colouring agent CI 42555-1

Colouring agent CI 42555-2]

381.

[F20Amyl 4-dimethylaminobenzoate, mixed isomers (Padimate A (INN))

382.

[F21. . . . .]

383.

2-Amino.4-nitrophenol

384.

2-Amino-5-nitrophenol]

385.

[F911 α-Hydroxypregn-4-ene-3,20-dione and its esters

385.

[F1511α-Hydroxypregn-4-ene-3, 20-dione) and its esters]

386.

[F14. . . . .]

386.

[F15Colouring agent C.I. 42 640]

387.

Colouring agent CI 13 065

388.

Colouring agent CI 42 535

389.

Colouring agent CI 61 554]

390.

[F14. . . . .

391.

. . . . .

392.

. . . . .

393.

. . . . .

394.

. . . . .]

390.

[F15Anti-androgens of steroidal structure

391.

Zirconium and its compounds, with the exception of the substances listed under reference number 50 in Annex III, Part One, and the zirconium lakes, pigments or salts of the colouring agents listed in Annex IV, Part One, with reference number 3

393.

Acetonitrile

394.

Tetrahydrozoline and its salts]

395.

[F7Hydroxy-8-quinoline and its sulphate, except for the uses provided for in No 51 in Annex III, Part 1

396.

Dithio-2,2-bispyridine-dioxide 1,1' (additive with trihydrated magnesium sulphate) - (pyrithione disulphide + magnesium sulphate)

397.

Colouring agent CI 12075 and its lakes, pigments and salts

398.

Colouring agent CI 45170 and CI 45170:1

399.

Lidocaine]

400.

[F221,2-epoxybutane

401.

Colouring agent CI 15585

402.

Strontium lactate

403.

Strontium nitrate

404.

Strontium polycarboxylate

405.

Pramocaine

406.

4-ethoxy-m-phenylenediamine and its salts

407.

2,4-diaminophenylethanol and its salts

408.

Catechol

409.

Pyrogallol

410.

Nitrosamines

411.

[F5Secondary alkyl- and alkanolamines and their salts] ]

412.

[F234-Amino-2-nitrophenol]

413.

[F242-Methyl-m-phenylenediamine]

414.

[F134-tert-Butyl-3-methoxy-2,6-dinitrotoluene (Musk Ambrette)]

427.

[F25. . . . .]

416.

[F13Cells, tissues or products of human origin

417.

3,3-Bis(4-hydroxyphenyl)phthalide (Phenolphthalein*)]

418.

[F263-Imidazol-4-ylacrylic acid and its ethyl ester (urocanic acid)]

419.

[F27 [F28From the date referred to in Article 22(1) of Regulation (EC) No 999/2001 of the European Parliament and of the Council (3) , the specified risk materials as designated in Annex V to that Regulation, and ingredients derived therefrom.

Until that date, the specified risk materials as designated in Annex XI Part A to Regulation (EC) No 999/2001, and ingredients derived therefrom.]

However, tallow derivatives may be used provided that the following methods have been used and strictly certified by the producer:

  • [F29Transesterification or hydrolysis at at least 200 °C and at an appropriate corresponding pressure, for 20 minutes (glycerol, fatty acids and fatty acid esters),]

  • Saponification with NaOH 12M (glycerol and soap):

    • Batch process: at 95 °C for three hours

      or

    • Continuous process: at 140 °C, two bars ( 2 000  hPa) for eight minutes or equivalent conditions.]

420.

[F30Crude and refined coal tars]

421.

[F311,1,3,3,5,-Pentamethyl-4,6-dinitroindane (moskene)

422.

5- tert- Butyl-1,2,3-trimethyl-4,6-dinitrobenzene (musk tibetene).]

423.

[F32Alanroot oil ( Inula helenium ) (CAS No 97676-35-2), when used as a fragrance ingredient.

424.

Benzyl cyanide (CAS No 140-29-4), when used as a fragrance ingredient.

425.

Cyclamen alcohol (CAS No 4756-19-8), when used as a fragrance ingredient.

426.

Diethyl maleate (CAS No 141-05-9), when used as a fragrance ingredient.

427.

Dihydrocoumarine (CAS No 119-84-6), when used as a fragrance ingredient.

428.

2,4-Dihydroxy-3-methylbenzaldehyde (CAS No 6248-20-0), when used as a fragrance ingredient.

429.

3,7-Dimethyl-2-octen-1-ol (6,7-Dihydrogeraniol) (CAS No 40607-48-5), when used as a fragrance ingredient.

430.

4,6-Dimethyl-8- tert -butylcoumarin (CAS No 17874-34-9), when used as a fragrance ingredient.

431.

Dimethyl citraconate (CAS No 617-54-9), when used as a fragrance ingredient.

432.

7,11-Dimethyl-4,6,10-dodecatrien-3-one (CAS No 26651-96-7), when used as a fragrance ingredient.

433.

6,10-Dimethyl-3,5,9-undecatrien-2-one (CAS No 141-10-6), when used as a fragrance ingredient.

434.

Diphenylamine (CAS No 122-39-4), when used as a fragrance ingredient.

435.

Ethyl acrylate (CAS No 140-88-5), when used as a fragrance ingredient.

436.

Fig leaf absolute ( Ficus carica ) (CAS No 68916-52-9), when used as a fragrance ingredient.

437.

trans -2-Heptenal (CAS No 18829-55-5), when used as a fragrance ingredient.

438.

trans -2-Hexenal diethyl acetal (CAS No 67746-30-9), when used as a fragrance ingredient.

439.

trans -2-Hexenal dimethyl acetal (CAS No 18318-83-7), when used as a fragrance ingredient.

440.

Hydroabietyl alcohol (CAS No 13393-93-6), when used as a fragrance ingredient.

441.

6-Isopropyl-2-decahydronaphthalenol (CAS No 34131-99-2), when used as a fragrance ingredient.

442.

7-Methoxycoumarin (CAS No 531-59-9), when used as a fragrance ingredient.

443.

4-(4-Methoxyphenyl)-3-butene-2-one (CAS No 943-88-4), when used as a fragrance ingredient.

444.

1-(4-Methoxyphenyl)-1-penten-3-one (CAS No 104-27-8), when used as a fragrance ingredient.

445.

Methyl tran s-2-butenoate (CAS No 623-43-8), when used as a fragrance ingredient.

446.

7-Methylcoumarin (CAS No 2445-83-2), when used as a fragrance ingredient.

447.

5-Methyl-2,3-hexanedione (CAS No 13706-86-0), when used as a fragrance ingredient.

448.

2-Pentylidenecyclohexanone (CAS No 25677-40-1), when used as a fragrance ingredient.

449.

3,6,10-Trimethyl-3,5,9-undecatrien-2-one (CAS No 1117-41-5), when used as a fragrance ingredient.

450.

Verbena oil ( Lippia citriodora Kunth.) (CAS No 8024-12-2), when used as a fragrance ingredient.

451.

[X2Methyleugenol (CAS No 93-15-2)] except for normal content in the natural essences used and provided that the concentration does not exceed:

(a)

0,01 % in fine fragrance

(b)

0,004 % in eau de toilette

(c)

0,002 % in fragrance cream

(d)

0,001 % in rinse-off products

(e)

0,0002 % in other leave-on products and oral hygiene products.]

Editorial Information

Textual Amendments

Yn ôl i’r brig

Options/Help

Print Options

You have chosen to open the Whole Directive

The Whole Directive you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

Gweler y wybodaeth ychwanegol ochr yn ochr â’r cynnwys

Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Llinell Amser Newidiadau

Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.

Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.

Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill